Header Logo

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat. 2008 Sep; 111(1):27-44.

View in: PubMed